Related Experiment Video
Updated: Jun 12, 2025

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
Development of a Cohort Analytics Tool for Monitoring Progression Patterns in Cardiovascular Diseases: Advanced
Arindam Brahma1, Samir Chatterjee2, Kala Seal1
1Department of Information Systems and Business Analytics, College of Business, Loyola Marymount University, Los Angeles, CA, United States.
Insights
This study models cardiovascular disease (CVD) progression using patient data, revealing transition patterns and creating an analytics tool for clinical decision support. The model can predict chronic disease progression with minimal data.
Area of Science:
- Cardiovascular disease research
- Computational epidemiology
- Health informatics
Background:
- Cardiovascular diseases (CVDs) are the leading global cause of death, characterized by complex chronic progression.
- Physicians often use a
- watchful waiting
- strategy for chronic conditions, delaying interventions.
- Longitudinal patient data and stochastic modeling can reveal population-level disease progression patterns.
Purpose of the Study:
- To apply advanced stochastic modeling to longitudinal CVD patient data to uncover transition probabilities and progression patterns.
- To develop a computational model and a digital clinical cohort analytics artifact for demonstrating the model's actionability.
- To provide clinicians with data-driven insights for treatment and intervention strategies.
Main Methods:
- Utilized longitudinal data from 9 National Heart Lung and Blood Institute epidemiological cohort studies, comprising 1274 patients and 4839 CVD episodes over 16 years.
- Employed the continuous-time Markov chain method to model time-variant transitions between chronic disease states.
- Developed a computational artifact for cohort analytics and validated its clinical applications through expert interviews.
Main Results:
- Presented time-variant transition probabilities and patterns of CVD progression, identifying myocardial infarction (MI) to stroke as the fastest transition and MI to angina as the slowest.
- Congestive heart failure (44.2%) and stroke (25.7%) were identified as the most probable first CVD episodes.
- The developed artifact serves as an actionable eHealth tool, offering 9 identified use cases for clinical decision support.
Conclusions:
- Addressed the limitation of lacking actionable cohort-level decision support tools for CVD by developing a comprehensive 10-state Markov chain model.
- The stochastic model-embedded artifact facilitates efficient disease monitoring and intervention decisions using real-world patient data.
- The model's flexibility allows for the analysis of any chronic disease progression with basic patient episode data.
Background:
The World Health Organization (WHO) reported that cardiovascular diseases (CVDs) are the leading cause of death worldwide. CVDs are chronic, with complex progression patterns involving episodes of comorbidities and multimorbidities. When dealing with chronic diseases, physicians often adopt a "watchful waiting" strategy, and actions are postponed until information is available. Population-level transition probabilities and progression patterns can be revealed by applying time-variant stochastic modeling methods to longitudinal patient data from cohort studies. Inputs from CVD practitioners indicate that tools to generate and visualize cohort transition patterns have many impactful clinical applications. The resultant computational model can be embedded in digital decision support tools for clinicians. However, to date, no study has attempted to accomplish this for CVDs.
Objective:
This study aims to apply advanced stochastic modeling methods to uncover the transition probabilities and progression patterns from longitudinal episodic data of patient cohorts with CVD and thereafter use the computational model to build a digital clinical cohort analytics artifact demonstrating the actionability of such models.
Methods:
Our data were sourced from 9 epidemiological cohort studies by the National Heart Lung and Blood Institute and comprised chronological records of 1274 patients associated with 4839 CVD episodes across 16 years. We then used the continuous-time Markov chain method to develop our model, which offers a robust approach to time-variant transitions between disease states in chronic diseases.
Results:
Our study presents time-variant transition probabilities of CVD state changes, revealing patterns of CVD progression against time. We found that the transition from myocardial infarction (MI) to stroke has the fastest transition rate (mean transition time 3, SD 0 days, because only 1 patient had a MI-to-stroke transition in the dataset), and the transition from MI to angina is the slowest (mean transition time 1457, SD 1449 days). Congestive heart failure is the most probable first episode (371/840, 44.2%), followed by stroke (216/840, 25.7%). The resultant artifact is actionable as it can act as an eHealth cohort analytics tool, helping physicians gain insights into treatment and intervention strategies. Through expert panel interviews and surveys, we found 9 application use cases of our model.
Conclusions:
Past research does not provide actionable cohort-level decision support tools based on a comprehensive, 10-state, continuous-time Markov chain model to unveil complex CVD progression patterns from real-world patient data and support clinical decision-making. This paper aims to address this crucial limitation. Our stochastic model-embedded artifact can help clinicians in efficient disease monitoring and intervention decisions, guided by objective data-driven insights from real patient data. Furthermore, the proposed model can unveil progression patterns of any chronic disease of interest by inputting only 3 data elements: a synthetic patient identifier, episode name, and episode time in days from a baseline date.
More Related Videos
08:51Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
07:31Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
Published on: May 15, 2020
Related Concept Videos
Statistical Methods for Analyzing Epidemiological Data
Cancer Survival Analysis
Statistical Software for Data Analysis and Clinical Trials
Comparing the Survival Analysis of Two or More Groups
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
Introduction To Survival Analysis
The primary goal of survival analysis is to estimate survival time—the time...